Cancer and Soluble FAS

Bulletin of Experimental Biology and Medicine

Volumn 148, Issue 4, 2009, Pages 638-642

  Abbasova, S G ^a   Vysotskii, M M ^b   Ovchinnikova, L K ^c   Obusheva, M N ^c   Digaeva, M A ^b   Britvin, T A ^d   Bahoeva, K A ^b   Karabekova, Z K ^c   Kazantzeva, I A ^d   Mamedov, U R ^c   Manuchin, I B ^b   Davidov, M I ^c  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^d M F VLADIMIRSKY MOSCOW REGIONAL RESEARCH CLINICAL INSTITUTE   (Russian Federation)

Author keywords

Malignant and benign tumors; Prognosis; Serum; Soluble Fas

Indexed keywords

FAS ANTIGEN;

ADOLESCENT; ADRENAL CANCER; ADRENAL TUMOR; ADULT; AGED; ARTICLE; BENIGN TUMOR; BLOOD LEVEL; BONE TUMOR; BREAST TUMOR; CANCER INVASION; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; CLINICAL FEATURE; COLORECTAL CANCER; FEMALE; HISTOGENESIS; HUMAN; INTESTINE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MYOMETRIUM; NEOPLASM; OSTEOSARCOMA; OVARY CANCER; OVARY TUMOR; SURVIVAL RATE; THYROID CANCER; UTERUS CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 77952092999     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-010-0784-8     Document Type: Article

References (10)

1. SG Abbasova ZhM Shcheprova AG Laman, et al. 2007 Byull. Eksp. Biol. Med. 144 10 395 400
2. J Cheng T Zhou C Liu, et al. 1994 Science 263 1759 1762 10.1126/science.7510905 1:CAS:528:DyaK2cXktVentL8%3D 7510905
3. Y Furuya O Nagakawa H Fuse 2003 Endocr. J. 50 5 629 633 10.1507/endocrj.50.629 14614220 (Pubitemid 37442839)
4. T Hara H Tsurumi M Takemara, et al. 2000 Am. J. Hematol. 64 4 257 261 10.1002/1096-8652(200008)64:4<257::AID-AJH4>3.0.CO;2-2 1:CAS:528:DC%2BD3cXmtVCjtLc%3D 10911377 (Pubitemid 30622232)
5. R Konno T Takano S Sato A Yajima 2000 Clin. Cancer Res. 6 9 3576 3580 1:CAS:528:DC%2BD3cXntFCisLg%3D 10999747
6. Y Mizutani O Yoshida O Ukimura, et al. 2002 Cancer Biother. Radiopharm. 17 5 563 567 10.1089/108497802760804790 12470426
7. N Niitsu K Sasaki M Umeda 1999 Leukemia 13 9 1434 1440 10.1038/sj/leu/2401502 1:STN:280:DyaK1MvhvVOhsw%3D%3D 10482996
8. PJ Perik WT Van der Graaf EG De Vries, et al. 2006 Acta Oncol. 45 2 175 183 10.1080/02841860500482225 1:CAS:528:DC%2BD28Xis1Cit7Y%3D 16546863
9. E Reichmann 2002 Semin. Cancer Biol. 12 4 309 315 10.1016/S1044-579X(02) 00017-2 1:CAS:528:DC%2BD38XlvVSjsb4%3D 12147205 (Pubitemid 35034575)
10. S Ugurel G Rappl W Tilgen U Reinhold 2001 Clin. Cancer Res. 7 5 1282 1286 1:STN:280:DC%2BD3M3lt1emsQ%3D%3D 11350895